Safety and Efficacy Study of GR68755 (Alosetron Hydrochloride) to Treat Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS)

NCT01855711 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Irritable Colon

Interventions

DRUG: GR68755 (Alosetron hydrochloride) 1 mg tablet

Sponsor

GlaxoSmithKline